Authors: ENSINGER HA BECHTEL WD BIRKE FW MENDLA KD MIERAU J SPECK G TROGER W

Citation: Ha. Ensinger et al., WAL-2014-FU (TALSACLIDINE) - A PREFERENTIALLY NEURON ACTIVATING MUSCARINIC AGONIST FOR THE TREATMENT OF ALZHEIMERS-DISEASE, Drug development research, 40(2), 1997, pp. 144-157

Authors: ENCABO A ROMANIN C BIRKE FW KUKOVETZ WR GROSCHNER K

Citation: A. Encabo et al., INHIBITION OF A STORE-OPERATED CA2-CELLS BY THE ISOQUINOLINE DERIVATIVE LOE-908( ENTRY PATHWAY IN HUMAN ENDOTHELIAL), British Journal of Pharmacology, 119(4), 1996, pp. 702-706

Authors: GOETZL EJ SHAMES RS YANG JH BIRKE FW LIU YF ALBERT PR AN SZ

Citation: Ej. Goetzl et al., INHIBITION OF HUMAN HL-60 CELL RESPONSES TO CHEMOTACTIC FACTORS BY ANTISENSE MESSENGER-RNA DEPLETION OF G-PROTEINS, The Journal of biological chemistry, 269(2), 1994, pp. 809-812